Product Information
ROFLUMILAST 250 MCG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $1.9069 per EA under NDC 72205020132. Its NADAC has been published 171 times since Mar 22, 2023.
Strength
250 ug/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205020132
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROFLUMILASTApproval Type
Generic (ANDA)
FDA Application
ANDA208256On Market Since
9/7/2022
Pharmacological Classes
Price Statistics
The NADAC for ROFLUMILAST 250 MCG TABLET has been published 171 times since Mar 22, 2023, and over the history we have for it it has declined 84.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9069 per EA |
|---|---|
| All-time high | $12.2673 (May 10, 2023) |
| All-time low | $1.5913 (Jul 17, 2024) |
| 52-week high | $2.4855 |
| 52-week low | $1.9069 |
| Median price | $2.4855 |
| Average price | $3.6748 |
| Largest weekly change | +63.4% (Aug 21, 2024) |
| Weeks tracked | 171 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROFLUMILAST 250 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROFLUMILAST 250 MCG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $1.9069 per EA (NDC 72205020132), effective Jun 24, 2026.
How has the price of ROFLUMILAST 250 MCG TABLET changed over time?
Over the history we have for it, the NADAC for ROFLUMILAST 250 MCG TABLET has declined 84.5%. It has been tracked across 171 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for ROFLUMILAST 250 MCG TABLET?
Since Mar 22, 2023, the NADAC for ROFLUMILAST 250 MCG TABLET has ranged from a low of $1.5913 (Jul 17, 2024) to a high of $12.2673 (May 10, 2023), with a median of $2.4855 per EA.
Are there cheaper alternatives to ROFLUMILAST 250 MCG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as ROFLUMILAST 250 MCG TABLET, but none are currently priced below it.
Who manufactures ROFLUMILAST 250 MCG TABLET?
ROFLUMILAST 250 MCG TABLET (NDC 72205020132) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification